|
Market Report
|
New technologies, growth opportunities, and the future market outlook
‘Innovations in In-Vitro Diagnostics' provides an in-depth analysis of emerging opportunities and potential clinical advances across the diagnostics markets of coronary heart disease, heart failure, bacterial infections and viral infections.
|
|
Read more...
|
|
|
Market Report
|
Accelerating Lead Generation: Emerging technologies and strategies
This report provides an in-depth examination of state-of-the-art technologies for lead generation.
|
|
Read more...
|
|
|
Market Report
|
The Top 10 Biosimilar Players: Positioning, performance and SWOT analyses
Biologics continue to outperform the global pharma market, driven by premium priced therapies for conditions that cannot be managed by conventional drugs. The rapid penetration of novel biologics and the gradual expiry of their patents will create significant market opportunities for biosimilars developers through to 2016.
|
|
Read more...
|
|
|
Market Report
|
Maximizing opportunities towards achieving clinical success
For the last few years the biggest pharma companies have started to bring new technologies for drug safety prediction into the discovery phases of research. This report will describe these technologies, their place in the drug discovery and development paradigm and their value for improving drug safety.
|
|
Read more...
|
|
|
Market Report
|
Forecast Analysis
The high cost and utilization of biologic drugs, coupled to the growing need to curb pharmaceutical expenditure, provides considerable momentum to the emerging biosimilars market. With a biosimilar approval pathway in place in Europe and Japan, and imminently in the US, Datamonitor expects payer pressure to drive biosimilar uptake, particularly in Germany, the US, and the UK.
|
|
Read more...
|
|
|
Market Report
|
Physician perception of biologics in autoimmune disease - Targeted detailing is the key to success
Factors influencing a prescribing decision can diverge from clinical facts. In the highly competitive autoimmune area, misconceptions and physician habits can result in loss of sales. Targeted detailing of specialist physicians, differentiating by indications is the key to success. Datamonitor has surveyed gastroenterologists, rheumatologists and dermatologists on attribute and brand perceptions
|
|
Read more...
|
|
|
Market Report
|
New Approaches to Pharma R&D: Evolving strategies to rejuvenate R&D efficiency
With industry consolidation, the economic downturn, and an increasing threat from generics, pharma companies are coming under greater pressure to fill their pipelines with innovative drugs. However, despite the costs and risks involved in drug development, the pharma industry is finding new ways to streamline the R&D process in an effort to increase efficiency and output.
|
|
Read more...
|
|
|
Market Report
|
Pricing and Reimbursement in Key Asia Pacific Markets
With the Asia-Pacific markets growing rapidly, they are becoming increasingly attractive for Pharma to enter. However, a number of key P&R developments and reforms are set to change the healthcare environment in the next few years, as healthcare is made more accessible to the poor and elderly.
|
|
Read more...
|
|
|
Market Report
|
Key Trends in Offshoring Pharmaceutical R&D: Company strategies, emerging markets and impact on ROI
‘Key Trends in Offshoring Pharmaceutical R&D' is a report published by Business Insights that evaluates the offshore R&D strategies that can reduce development times and improve productivity, with analysis of a variety of strategic partnerships, academic collaborations, and outsourcing opportunities.
|
|
Read more...
|
|
|
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>
|
| Results 64 - 72 of 324 |
Farmavita.Net Journal 
